Microchip Technology (NASDAQ: MCHP) Posts 38% Revenue Jump, Raises Q2 Outlook

Microchip Technology (NASDAQ: MCHP) reported fiscal first-quarter 2027 results for the period ended June 30, 2026, with net sales of $1.485 billion rising 38.0% year over year and 13.2% sequentially, exceeding the company's own guidance midpoint of $1.456 billion. Adjusted EPS came in at $0.76, beating the $0.71 consensus estimate by 7.0%, while GAAP EPS reached $0.37, well above prior guidance of $0.28 to $0.29 per diluted share. Shares gained 13.89% on Friday, August 7, 2026, while the S&P 500 advanced 0.61%.

Q1 FY2027 Results

• Revenue: $1.485 billion, up 38.0% from $1.076 billion in the year-ago quarter, above the high end of guidance.
• Adjusted EPS: $0.76 per diluted share, versus $0.27 in Q1 FY2026, a 181.5% year-over-year increase; beat the $0.71 consensus by 7.0%.
• GAAP EPS: $0.37 per diluted share, compared to a GAAP loss of $0.09 per diluted share in Q1 FY2026.
• Adjusted operating income: $521.1 million, representing a 35.1% adjusted operating margin.
• GAAP operating income: $336.8 million, or 22.7% of net sales.
• Gross margin: GAAP gross profit of 63.2%; adjusted gross profit of 63.8%, above the high end of guidance.
• Balance sheet: Net debt reduced by approximately $170 million during the quarter; quarterly common stock dividend declared at $0.455 per share for the September quarter.

What Drove the Results

Adjusted EPS of $0.76 beat the $0.71 consensus estimate, and net sales of $1.485 billion exceeded the top of Microchip's guided range. The company cited improving demand, continued inventory normalization, and stronger factory utilization as the primary operational drivers. Inventory days declined from 185 days at March 31 to 175 days at June 30, and distribution sell-through increased meaningfully during the quarter.

The gap between GAAP net income of $202.0 million and adjusted net income of $438.6 million reflects the impact of amortization of acquired intangible assets from previous acquisitions, share-based compensation, and restructuring-related charges. On the product side, PCIe Gen6 connectivity design wins doubled sequentially, from six programs at the end of the March quarter to 12 programs exiting June, reflecting increased traction in data center and connectivity applications.

Q2 FY2027 Outlook

For the September quarter, Microchip guided net sales to $1.589 billion to $1.618 billion, implying sequential growth of 7% to 9% and year-over-year growth of approximately 40.6% at the midpoint. Adjusted EPS guidance of $0.91 to $0.95 compares favorably to Q1's $0.76 result. GAAP EPS is guided at $0.53 to $0.54. Adjusted gross margin is expected in the range of 66.0% to 67.0%, and adjusted operating margin is guided at 38.5% to 39.5%. Full-year FY2027 capital expenditures are expected to total approximately $100 million, with Q2 capex targeted at $20 million to $25 million.

Wall Street View

Analyst sentiment on Microchip entering the report was firmly constructive, with the most recent consensus reflecting 25 Buy or Strong Buy ratings against 7 Hold ratings and no Sell recommendations as of August 1, 2026. The Q1 beat and raised Q2 outlook provide concrete figures to anchor any potential target revisions, though specific updated price targets from individual firms were not available in the source data at publication time.

Investor Takeaway

Microchip's Q1 FY2027 results confirm that the recovery underway is translating into meaningful operating leverage, with adjusted operating margin expanding to 35.1% and the company generating sufficient cash to reduce net debt by $170 million in a single quarter. The forward guidance for 40.6% year-over-year revenue growth at the Q2 midpoint, combined with expanding gross margin guidance of 66.0% to 67.0% on an adjusted basis, suggests the profitability recovery still has room to run as factory utilization continues to improve.